创业板融资余额八连降

Core Points - The financing balance of the ChiNext board has decreased for eight consecutive trading days, totaling a reduction of 12.23 billion yuan during this period [1][2] - As of March 28, 2025, the total margin balance of the ChiNext board was 369.25 billion yuan, with a decrease of 1.467 billion yuan from the previous trading day [1][2] Financing Balance Changes - The financing balance on March 28, 2025, was 368.28 billion yuan, down by 1.44 billion yuan from the previous day [2] - A total of 372 stocks saw an increase in financing balance, with 54 stocks experiencing an increase of over 20% [2][3] - The stock with the highest increase in financing balance was Duorui Pharmaceutical, which saw a 173.35% increase, bringing its latest financing balance to 75.36 million yuan [2][3] Stocks with Significant Changes - Among the stocks with a financing balance increase, Duorui Pharmaceutical, Deshi Co., and Huisheng Biological had increases of 173.35%, 103.03%, and 96.75%, respectively [3][4] - Conversely, the stock with the largest decrease was Wanjian Medical, which saw a 44.01% drop in financing balance, now at 97.72 million yuan [3][4] Market Performance - Stocks with a financing balance increase of over 20% averaged a rise of 3.68%, outperforming the ChiNext index [5] - Notable gainers included Huisheng Biological, Jiangtian Chemical, and Xinlai Materials, with increases of 86.99%, 46.75%, and 42.29%, respectively [5] - Significant decreases were observed in Hongjing Optoelectronics, Hanshuo Technology, and Dingtai High-Tech, with declines of 27.53%, 20.45%, and 18.36% [5] Financing Balance Rankings - The stock with the highest increase in financing balance was Xinlai Materials, which increased by 259 million yuan, bringing its total to 605 million yuan [5][6] - The largest decrease in financing balance was seen in Dongfang Fortune, which dropped by 809 million yuan, now at 24.48 billion yuan [5][6]